Decriminalized Possession of Hard Drugs Takes Effect in Oregon
by Kat Helgeson
During the first-ever cannabis-focused House Energy and Commerce Health subcommittee hearing yesterday, lawmakers prodded officials on the federal limitations to researching the plant and its status as a Schedule I substance. Officials from the US Food and Drug Administration, the US Drug Enforcement Administration and the National Institutes of Health provided testimony. Cannabis remains a Schedule I substance — the most restrictive class — because of a lack of comprehensive research. Research, however, is hindered because of the classification.
No votes were cast nor policy decisions made, but this meeting did provide a peek into legislators’ temperatures on cannabis legalization. In this first-ever, 3.5 hour-long meeting – the sub-committee also discussed the actions undertaken to-date by the slew of government agencies wielding significant influence over how cannabis is currently researched, possessed and consumed.
Because cannabis is a Schedule I, meaning it has no medicinal value and a high potential for abuse, researchers have a hard time getting the proper licenses to research it and offer the government proof of its medicinal value. Not widely supported but, the DEA could remove cannabis’ status as a Schedule I drug or change its status on the federal drug schedule without Congressional approval. Descheduling cannabis would indeed accelerate research according to this logic.
Some representatives feel that descheduling may give unclear impressions including decreased perceptions of risk and potential harm to health. However current contradictory legislations between federal and state on cannabis- has even more consumers at risk. Without proper policy and federal regulation, the industry and cannabis consumers remain vulnerable.
The cannabis industry is caught in the middle of a conflict in federal and state laws — a predicament that is only worsened by thin scientific data. The University of Mississippi remains the sole supplier of research-grade cannabis for federally approved trials. And the cannabis that’s available for research has been assailed by scientists as “sub-par” material that does not accurately represent the diverse array of products — and potencies — available for sale in states that have legalized recreational cannabis. Research-grade marijuana that’s supplied by the only federally authorized cultivation site in the United States is genetically closer to hemp than cannabis varieties sold at dispensaries in legal states.
Researchers also face time-consuming and costly hurdles in completing the complicated federal application process for using cannabis in long-term clinical trials. In 2017, the Drug Enforcement Administration (DEA) had been gearing up to allow facilities other than the University of Mississippi to grow pot for research. But after they received 26 applications from other growers, then U.S. Attorney General Jeff Sessions halted the initiative.
The lack of cannabis research on currently available genetics poses a public health risk. As the United States struggles with the basics of cannabis research, such as providing proper cannabis to researchers, other countries have lept ahead. One of the foremost is Israel, where many in the marijuana field believe the most innovative research is happening. While research in the United States remains strangled in a Schedule 1 chokehold, Israelis are diligently engaged in cannabis R&D, fueled by the country’s relatively supportive regulatory climate, well-established research infrastructure, and hyperactive entrepreneurial spirit.
This blog was originally written by Anthony Dutcher but has been updated with new information as states continue to change their regulations nationwide. Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states…
Transporting cannabis is a tricky business, thanks in large part to the fact that cannabis is still illegal at the federal level. Even when you’re transporting cannabis from a state where it’s legal to another state where it’s legal—for example, driving across the border from California to Oregon—there’s a chance you might run into trouble….
Jamaica is facing a major cannabis shortage. Spanish Town, Port Antonio, Montego Bay, and the island capital, Kingston, are all running short on herb. The island of Jamaica is known for reggae music and big spliffs. Hearing that there’s a shortage of cannabis is leaving many people scratching their heads in dismay. Jamaica without weed…
Cannabis glass art is a functional art of spectacular proportions. There are many different variances of functional glass art created by a multitude of talented individuals. Glass and grass go hand in hand for many people. Glass pipes provide smooth, clean-tasting hits, and people love the endless possibilities of their designs. It wasn’t but a…
Asthma can cause permanent lung damage due to persistent coughing and wheezing- which is exactly why patients should take preventative measures to minimize coughing and wheezing. A recently published study, which includes a survey, found that a surprising amount of asthma patients smoke cannabis, despite the fact that it may induce coughing. The cannabinoids from…
New Jersey has launched a cannabis institute to help professionals further their education in cannabis. California has introduced a bill to help…
We kind of already knew that the Queen of England was a pretty amazing woman. Elizabeth II, Queen of the United Kingdom,…
Note: Veriheal does not support illegally consuming therapeutic substances like cannabis and psilocybin but acknowledges that it transpires because of the current…